Results 121 to 130 of about 192 (134)

[Targeting BCMA in multiple myeloma using chimeric antigen receptor-engineered T cells]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2019
Zhong MJ   +7 more
europepmc   +1 more source

[Mechanism of NKG2D ligands-mediated immune escape of adriamycin resistant leukemia K562/A02 cells]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2018
Jia ZX   +8 more
europepmc   +1 more source

[Advances in the mouse models of myeloid leukemia]. [PDF]

open access: yesSheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2019
Ge C, Fu C.
europepmc   +1 more source

[An experimental study of CD4 targeted chimeric antigen receptor modified T cell with anti-lymphoma activity]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2018
Chen GH   +16 more
europepmc   +1 more source

[Effect of bortezomib in inducing apoptosis of imatinib-resistant K562 cells and the mechanism]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2017
Hua JY, Zhou XH, Ouyang ST, Wu YB.
europepmc   +1 more source

[Observation on the efficacy of consolidation chemotherapy combined with allogeneic natural killer cell infusion in the treatment of low and moderate risk acute myeloid leukemia]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2019
Wang CJ   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy